title: Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.
abstract: Liposomes have been investigated extensively as a vaccine delivery system. Herein the adjuvant activities of liposomes with different net surface charges (neutral, positive, or negative) were evaluated when admixed with protein antigens, ovalbumin (OVA, pI = 4.7), Bacillus anthracis protective antigen protein (PA, pI = 5.6), or cationized OVA (cOVA). Mice immunized subcutaneously with OVA admixed with different liposomes generated different antibody responses. Interestingly, OVA admixed with net negatively charged liposomes prepared with DOPA was as immunogenic as OVA admixed with positively charged liposomes prepared with DOTAP. Immunization of mice with the anthrax PA protein admixed with the net negatively charged DOPA liposomes also induced a strong and functional anti-PA antibody response. When the cationized OVA was used as a model antigen, liposomes with net neutral, negative, or positive charges showed comparable adjuvant activities. Immunization of mice with the OVA admixed with DOPA liposomes also induced OVA-specific CD8(+) cytotoxic T lymphocyte responses and significantly delayed the growth of OVA-expressing B16-OVA tumors in mice. However, not all net negatively charged liposomes showed a strong adjuvant activity. The adjuvant activity of the negatively charged liposomes may be related to the liposome's ability (i) to upregulate the expression of molecules related to the activation and maturation of antigen-presenting cells and (ii) to slightly facilitate the uptake of the antigens by antigen-presenting cells. Simply admixing certain negatively charged liposomes with certain protein antigens of interest may represent a novel platform for vaccine development.
authors: Pharmaceutics Division, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, USA.
authors: Nijaporn
authors: N
authors: Yanasarn
authors: Brian R
authors: BR
authors: Sloat
authors: Zhengrong
authors: Z
authors: Cui
references: Vaccine. 2009 Jun 12;27(29):3912-20
references: 19490987
references: J Immunol Methods. 1991 Jun 24;140(1):1-13
references: 1712030
references: Infect Immun. 2002 Dec;70(12):6697-706
references: 12438344
references: J Immunol Methods. 1993 Dec 3;166(2):271-80
references: 8288880
references: J Liposome Res. 2009;19(1):2-11
references: 19515003
references: Infect Immun. 1997 Jun;65(6):2371-7
references: 9169776
references: Clin Vaccine Immunol. 2009 Oct;16(10):1383-92
references: 19675224
references: Mol Pharm. 2005 Jan-Feb;2(1):22-8
references: 15804174
references: Immunology. 1982 Feb;45(2):349-56
references: 7037620
references: Vaccine. 2001 Feb 8;19(13-14):1794-805
references: 11166905
references: Eur J Immunol. 1999 May;29(5):1617-25
references: 10359116
references: Biosci Rep. 1984 Feb;4(2):99-107
references: 6713089
references: Vaccine. 2009 Oct 30;27(46):6399-403
references: 19552895
references: Nature. 1974 Nov 15;252(5480):252
references: 4424229
references: Exp Parasitol. 2009 Apr;121(4):362-9
references: 19211022
references: Int Arch Allergy Immunol. 2001 Dec;126(4):257-66
references: 11815732
references: Mol Membr Biol. 2006 Sep-Oct;23(5):385-95
references: 17060156
references: Int J Pharm. 2009 Feb 23;368(1-2):56-62
references: 18992312
references: Vaccine. 1995 Dec;13(18):1809-14
references: 8701598
references: Immunol Lett. 1989 Feb;20(3):237-40
references: 2714847
references: Biochim Biophys Acta. 1984 May 30;772(3):288-94
references: 6547057
references: Immunology. 1982 Dec;47(4):627-32
references: 6754583
references: Blood. 2000 Sep 15;96(6):2206-14
references: 10979967
references: Vaccine. 2006 Jul 17;24(29-30):5708-17
references: 16740346
references: J Control Release. 1999 Aug 27;61(1-2):233-40
references: 10469918
references: Curr Opin Microbiol. 2005 Feb;8(1):106-12
references: 15694864
references: Pharm Res. 2006 Jun;23(6):1217-26
references: 16718616
references: Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7915-8
references: 1518813
references: Annu Rev Biophys Bioeng. 1980;9:467-508
references: 6994593
references: J Immunol. 1987 Feb 1;138(3):833-7
references: 2433331
references: Immunology. 1983 Sep;50(1):101-6
references: 6193054
references: J Immunol. 1998 Sep 15;161(6):3096-102
references: 9743376
references: J Control Release. 2010 Jan 25;141(2):199-207
references: 19818373
references: Life Sci. 1994;55(7):499-509
references: 8041229
references: Can Vet J. 1990 Mar;31(3):181-9
references: 17423533
references: Cancer Immunol Immunother. 2008 Apr;57(4):517-30
references: 17724588
references: Vaccine. 2009 Nov 16;27(49):6939-49
references: 19748578
references: Vaccine. 2006 Jun 12;24(24):5158-68
references: 16713037
references: Infect Immun. 1998 Jun;66(6):2859-65
references: 9596760
references: Mol Immunol. 2007 Jul;44(15):3672-81
references: 17521728
references: Int J Pharm. 2002 May 15;238(1-2):229-39
references: 11996826
references: Vaccine. 2007 Jul 20;25(29):5256-62
references: 17583394
references: Vaccine. 2001 Feb 28;19(15-16):1911-23
references: 11228361
references: Methods. 2006 Sep;40(1):10-9
references: 16997709
references: J Control Release. 2010 Jan 4;141(1):93-100
references: 19729045
references: Vaccine. 2004 Sep 3;22(25-26):3503-9
references: 15308378
references: J Infect Dis. 1994 Jan;169(1):55-61
references: 8277198
references: J Immunother. 2007 Feb-Mar;30(2):180-9
references: 17471165
references: Hepatology. 2003 Feb;37(2):452-60
references: 12540796
references: J Infect Dis. 2004 Aug 15;190(4):774-82
references: 15272406
references: J Immunol. 2005 Jun 15;174(12):7516-23
references: 15944250
references: Immunol Lett. 1987 Apr;14(4):341-8
references: 3583325